On July 20, Guardant Health fell 5.06% in regular trading, trading at $148.395 USD/share, with Turnover of $75.72 million.
Within the Health Care Services sector where Guardant Health belongs, among individual stocks, BrightSpring Health Services Inc. up 1.92%, Hims & Hers Health Inc. up 1.22%, THE CIGNA GROUP up 0.99%, CVS Health up 0.03%, BillionToOne, Inc. down 4.88%.
Guardant Health is a leading precision oncology company providing blood and tissue tests, real-world data, and AI-powered analytics. Its testing covers early cancer screening, recurrence monitoring, and advanced treatment selection. The company's next earnings report is expected to be released after market close on July 30.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments